Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
2 clinical trials · Condition
◉ Watch Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
| Record | Firm | Date |
|---|---|---|
| mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA (NCT03045770) | Fujian Cancer Hospital | 2017-02-10 |
| Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA (NCT03030937) | Fujian Cancer Hospital | 2017-02-01 |
Track Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction automatically
Every clearance here is in the API, with alerts when new ones post.